C58. MECHANISMS OF PULMONARY FIBROSIS

查看最新文献

503

C58. MECHANISMS OF PULMONARY FIBROSIS - 最新文献

Pre-Clinical GMP Toxicology Study for the Drug Development of Idopathic Pulmonary Fibrosis (IPF) Using a Novel RNAi-Based Nanoparticle Technology (SAMiRNATM)

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7405 T. Kim

Identification and PK/PD Assessment of an Oral, Selective, avb6/ avb1 Dual Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5236 S. Turner, E. Lepist, F. Rock, M. Decaris, J. Schaub, C. Chen, P. Andre

Cellular Uptake of a Novel siRNA-Based Oligonucleotide, TRK-250 in Lung Cells

Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5242 M. Yamada, A. Izawa, A. Shibata, T. Matsumoto, Y. Eguchi, H. Inada, W. Toriumi, Y. Miyamoto

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。